MoneyWorks4Me

Aarti Pharmalabs - Quaterly Results

12 May 2023 Evaluate
The Total revenue for the quarter ended March 2023 of  Rs. 3742.70 millions remain, more or less, the same.The Net proft of the company remain more or less same to Rs. 400.00  millions from Rs. 448.80 millions ,decline by -10.87%.The company reported a good operating profit of 768.00 millions compared to 707.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 3742.70 3647.00 2.62 15112.50 9410.20 60.60 15112.50 9410.20 60.60
Other Income 0.00 25.10 -100.00 12.80 25.10 -49.00 12.80 25.10 -49.00
PBIDT 768.00 707.20 8.60 3096.20 1822.90 69.85 3096.20 1822.90 69.85
Interest 58.00 44.00 31.82 204.90 113.40 80.69 204.90 113.40 80.69
PBDT 710.00 663.20 7.06 2891.30 1709.50 69.13 2891.30 1709.50 69.13
Depreciation 142.50 124.40 14.55 557.70 372.30 49.80 557.70 372.30 49.80
PBT 567.50 538.80 5.33 2333.60 1337.20 74.51 2333.60 1337.20 74.51
TAX 167.50 90.00 86.11 616.30 270.00 128.26 616.30 270.00 128.26
Deferred Tax 27.50 15.00 83.33 95.00 45.00 111.11 95.00 45.00 111.11
PAT 400.00 448.80 -10.87 1717.30 1067.20 60.92 1717.30 1067.20 60.92
Equity 453.10 455.60 -0.55 453.10 455.60 -0.55 453.10 455.60 -0.55
PBIDTM(%) 20.52 19.39 5.82 20.49 19.37 5.76 20.49 19.37 5.76
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..